Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Aguora Hills, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncotelic Therapeutics, Inc. has filed 1,204 SEC EDGAR filings since 04 Apr 1996

SEC filing history

Showing 326-350 of 770 matching filings.

Per page
25
Current page
14
S-1/A File 333-217904

S-1/A

Filing date
13 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
12 Jun 2017
Reporting date
12 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
09 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
07 Jun 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-217904

S-1

Filing date
11 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-21990

DEFA14A

Filing date
26 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-21990

DEFINITIVE PROXY STATEMENT

Filing date
26 Apr 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
24 Apr 2017
Reporting date
24 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
18 Apr 2017
Reporting date
18 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-217038

S-8

Filing date
30 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
15 Mar 2017
Reporting date
15 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 000-21990

25-NSE filing

Filing date
25 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jan 2017
Reporting date
12 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jan 2017
Reporting date
12 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jan 2017
Reporting date
12 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
13 Jan 2017
Reporting date
12 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45691

SABBY 13G-A MATN 1.05.17

Filing date
05 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2016
Reporting date
16 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
15 Dec 2016
Reporting date
09 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
06 Dec 2016
Reporting date
06 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .